Daewoong pharmaceutical

069620.KO

119.16 USD

8.00

+7.20%

Overview

Last close

119.16 usd

Market cap

1.37B usd

52 week high

123.18 usd

52 week low

72.15 usd

Target price

145.03 usd

Valuation

P/E

N/A

Forward P/E

N/A

Price/Sales

1.3437

Price/Book Value

2.2511

Enterprise Value

1.69B usd

EV/Revenue

1.6404

EV/EBITDA

16.5672

Key financials

Revenue TTM

1.03B usd

Gross Profit TTM

531.20M usd

EBITDA TTM

151.65M usd

Earnings per Share

N/A usd

Dividend

0.41 usd

Total assets

1.56B usd

Net debt

422.10M usd

About

Daewoong Pharmaceutical Co., Ltd. develops, manufactures and commercializes pharmaceutical products in South Korea and internationally. It offers products in therapeutic areas, such as central nervous system, endocrinology, musculoskeletal, nephrology, antineoplastic, cardiovascular, gastrointestinal, metabolic, antiviral, analgesic, antacid, and digestive diseases, as well as wound, iron supplements, and muti-vitamins. The company also provides COVID-19 PCR kit, COVID-19 IgG/IgM RDT, and viral transport medium medical devices. The company was founded in 1945 and is headquartered in Seoul, South Korea.